Consainsights logo
Reports > Life Sciences > Gastric Balloons Market Report

Gastric Balloons Market Size, Share, Industry Trends and Forecast to 2033

This report provides a comprehensive analysis of the gastric balloons market from 2023 to 2033, detailing market size, trends, technological advancements, and regional insights to aid stakeholders in strategic decision-making.

Metric Value
Study Period 2023 - 2033
2023 Market Size $3.00 Billion
CAGR (2023-2033) 7.0%
2033 Market Size $6.01 Billion
Top Companies Apollo Endosurgery, Ethicon Inc., Allergan
Last Modified Date 15 Nov 2024

Gastric Balloons Market Report (2023 - 2033)

Gastric Balloons Market Overview

The gastric balloons industry is marked by significant innovations and competitive dynamics. Key players are focused on developing advanced products with improved safety profiles and increased patient comfort. Regulatory frameworks continue to evolve, influencing how products are developed and marketed. This sector is also benefitting from heightened consumer awareness about obesity management and the advantages of less invasive options. Collaborations and partnerships among manufacturers and healthcare providers are common, fostering growth and expanding market reach.

What is the Market Size & CAGR of the Gastric Balloons market in 2023?

As of 2023, the gastric balloons market is projected to be valued at approximately $4.07 billion. The market is expected to grow rapidly at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2033. This growth can be attributed to increasing obesity rates globally, changing lifestyles, and a growing preference for non-surgical weight-loss methods, which enhance the appeal of gastric balloons as a viable option for patients seeking weight management solutions.

Gastric Balloons Industry Analysis

The gastric balloons industry is marked by significant innovations and competitive dynamics. Key players are focused on developing advanced products with improved safety profiles and increased patient comfort. Regulatory frameworks continue to evolve, influencing how products are developed and marketed. This sector is also benefitting from heightened consumer awareness about obesity management and the advantages of less invasive options. Collaborations and partnerships among manufacturers and healthcare providers are common, fostering growth and expanding market reach.

Gastric Balloons Market Segmentation and Scope

The gastric balloons market is segmented based on product type, application, end-user, distribution channel, and end-user demographics. The primary product types include intragastric balloons and brands such as ORBERA and Revirol. Applications range from weight management to pre-operative assistance and rehabilitation, catering to various patient needs. The end-users include hospitals, clinics, and home care settings, reflecting the versatility of these devices. Understanding these segments is crucial for stakeholders aiming to target specific consumer demographics and address market demands effectively.

Request a custom research report for industry.

Gastric Balloons Market Analysis Report by Region

Europe Gastric Balloons Market Report:

The European region is witnessing substantial growth, with the market expected to increase from $0.78 billion in 2023 to $1.56 billion by 2033. This is supported by robust healthcare policies and increasing investment in obesity treatment technologies, combined with a high prevalence of obesity across several European countries.

Asia Pacific Gastric Balloons Market Report:

In the Asia Pacific region, the gastric balloons market is projected to reach $1.23 billion by 2033, growing from $0.61 billion in 2023. This growth is driven by rising obesity rates and increasing healthcare expenditure, as well as the introduction of innovative gastric balloon systems in key markets such as China and India.

North America Gastric Balloons Market Report:

North America is a significant market for gastric balloons, projected to double from $1.15 billion in 2023 to $2.31 billion in 2033. The increasing prevalence of obesity and a growing number of weight-loss clinics are key drivers, along with advanced healthcare technologies and broader acceptance of non-surgical procedures.

South America Gastric Balloons Market Report:

The South American market is expected to grow from $0.23 billion in 2023 to $0.46 billion by 2033. Factors contributing to this growth include increasing awareness of obesity-related health issues and the expanding healthcare infrastructure that promotes obesity management solutions.

Middle East & Africa Gastric Balloons Market Report:

In the Middle East and Africa, the market is anticipated to grow from $0.23 billion in 2023 to $0.45 billion by 2033. Efforts to enhance healthcare systems, coupled with an increase in lifestyle-related diseases, are driving demand for gastric balloon products in this region.

Request a custom research report for industry.

Gastric Balloons Market Analysis By Product

Global Gastric Balloons Market, By Product (2023 - 2033)

Overall, the gastric balloons market saw intragastric balloons lead with a size of $2.03 billion in 2023, projected to reach $4.07 billion by 2033 while holding a 67.72% market share. Specific brands like ORBERA and Revirol are crucial market players, having values of $0.65 billion and $0.32 billion respectively in 2023, both expected to show significant growth by 2033.

Gastric Balloons Market Analysis By Application

Global Gastric Balloons Market, By Application (2023 - 2033)

The applications of gastric balloons include weight management, pre-operative assistance, and rehabilitation. Weight management significantly dominates this segment, valued at $2.03 billion in 2023, while pre-operative assistance and rehabilitation hold smaller portions of $0.65 billion and $0.32 billion respectively, with all segments anticipated to grow by 2033.

Gastric Balloons Market Analysis By End User

Global Gastric Balloons Market, By End-User (2023 - 2033)

Hospitals, clinics, and home care settings are the primary end-users. The hospital segment leads with $2.03 billion in 2023, projected to grow to $4.07 billion by 2033. Clinics follow with $0.65 billion in 2023, doubling by 2033, while home care demonstrates an emerging potential in providing weight management solutions.

Gastric Balloons Market Analysis By Distribution Channel

Global Gastric Balloons Market, By Distribution Channel (2023 - 2033)

Direct sales, online sales, and third-party distributors are crucial distribution channels in the gastric balloons market. Direct sales dominate with revenues of $2.03 billion in 2023, while online sales and third-party distributors represent $0.65 billion and $0.32 billion respectively. All segments are expected to expand significantly towards 2033.

Gastric Balloons Market Analysis By End User Demographics

Global Gastric Balloons Market, By End-User Demographics (2023 - 2033)

The primary demographic for gastric balloons includes adult patients, accounting for 87.5% of the market, with an expected growth from $2.63 billion in 2023 to $5.26 billion by 2033. Pediatric patients represent a smaller segment but are also showing potential with a projected increase in demand.

Gastric Balloons Market Trends and Future Forecast

The gastric balloons market is anticipated to follow significant trends, including rising technological innovations, increased insurance coverage for obesity treatments, and growing acceptance of non-invasive procedures. The forecast to 2033 indicates robust growth, supported by an expanding patient demographic and increased awareness of obesity health risks. Challenges such as regulatory hurdles and competition from alternative weight management solutions may affect this growth, yet the overall outlook remains positive.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Gastric Balloons Industry

Apollo Endosurgery:

A leading global provider of minimally invasive medical devices, Apollo specializes in endoscopic gastric balloons and is driving innovation in the weight management sector.

Ethicon Inc.:

A subsidiary of Johnson & Johnson, Ethicon offers advanced medical devices, including gastric balloons that are instrumental in non-invasive weight loss solutions.

Allergan:

Known for its aesthetic products, Allergan also plays a key role in the gastric balloons market with its ORBERA product, which helps reduce obesity in patients.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs